Human dyskerin: Beyond telomeres

Biological Chemistry

Volumn 395, Issue 6, 2014, Pages 593-610

  Angrisani, Alberto ^a   Vicidomini, Rosario ^a   Turano, Mimmo ^a   Furia, Maria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

DKC1; dyskeratosis; H ACA snoRNPs; NAF1; pseudouridylation; SHQ1

Indexed keywords

DYSKERIN; PROTEIN P27; PROTEIN P53; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; SMALL NUCLEOLAR RNA; CELL CYCLE PROTEIN; DKC1 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ACETYLATION; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; APOPTOSIS; BASE PAIRING; BINDING AFFINITY; BIOGENESIS; BONE MARROW CELL; BONE MARROW DEPRESSION; BREAST CANCER; BREAST CANCER CELL LINE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COILED BODY; COLORECTAL CANCER; CRYSTAL STRUCTURE; CYTOPLASM; CYTOSOL; DISEASE PREDISPOSITION; DOSE RESPONSE; DROSOPHILA; EMBRYONIC STEM CELL; ENZYME ACTIVE SITE; EUKARYOTE; EUKARYOTIC CELL; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GROWTH RATE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMATOPOIETIC CELL; HUMAN; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL CARCINOMA; LUNG FIBROSIS; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MELANOMA; MITOSIS; MUTATION; NEUROBLASTOMA; NONHUMAN; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; OVARY CARCINOMA; OXIDATIVE STRESS; OXYGEN CONCENTRATION; PATHOGENESIS; PHOSPHORYLATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FAMILY; PROTEIN MODIFICATION; PROTEIN STABILITY; PSEUDOURIDYLATION; PYROCOCCUS FURIOSUS; REGULATORY MECHANISM; REVIEW; RIBOSOME; RIBOSOME SUBUNIT; RNA BINDING; RNA SPLICING; RNA TRANSCRIPTION; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SKIN FIBROBLAST; STEADY STATE; STEM CELL; STOP CODON; SUMOYLATION; T CELL LYMPHOMA; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; X RAY ANALYSIS; DYSKERATOSIS CONGENITA; GENETICS; METABOLISM;

CELL CYCLE PROTEINS; DYSKERATOSIS CONGENITA; HUMANS; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; TELOMERE;

EID: 84899472525     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0287     Document Type: Review

References (108)

1. Agarwal, S., Loh, Y.H., McLoughlin, E.M., Huang, J., Park, I.H., Miller, J.D., Huo, H., Okuka, M., Dos Reis, R.M., Loewer, S., et al. (2010). Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464, 292-296.
2. Alawi, F. and Lin, P. (2010). Loss of dyskerin reduces the accumulation of a subset of H/ACA snoRNA-derived miRNA. Cell Cycle 9, 2467-2469.
3. Alawi, F. and Lin, P. (2011). Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing. Mol. Carcinog. 50, 334-345.
4. Alawi, F. and Lin, P. (2013). Dyskerin localizes to the mitotic apparatus and is required for orderly mitosis in human cells. PLoS One 8, e80805.
5. Alter, B.P., Giri, N., Savage, S.A., and Rosenberg, P.S. (2009). Cancer in dyskeratosis congenita. Blood 113, 6549-6557.
6. Angrisani, A., Turano, M., Paparo, L., Di Mauro, C., and Furia, M. (2011). A new human dyskerin isoform with cytoplasmic localization. Biochim. Biophys. Acta 1810, 1361-1368.
7. Ballarino, M., Morlando, M., Pagano, F., Fatica, A., and Bozzoni, I. (2005). The cotranscriptional assembly of snoRNPs controls the biosynthesis of H/ACA snoRNAs in Saccharomyces cerevisiae. Mol. Cell Biol. 25, 5396-5403.
8. Batista, L.F., Pech, M.F., Zhong, F.L., Nguyen, H.N., Xie, K.T., Zaug, A.J., Crary, S.M., Choi, J., Sebastiano, V., Cherry, A., et al. (2011). Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399-402.
9. Bellodi, C., Krasnykh, O., Haynes, N., Theodoropoulou, M., Peng, G., Montanaro, L., and Ruggero, D. (2010). Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res. 70, 6026-6035.
10. Bellodi, C., McMahon, M., Contreras, A., Juliano, D., Kopmar, N., Nakamura, T., Maltby, D., Burlingame, A., Savage, S.A., Shimamura, A., et al. (2013). H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell. Rep. 3, 1493-1502.
11. Blomster, H.A., Hietakangas, V., Wu, J., Kouvonen, P., Hautaniemi, S., and Sistonen, L. (2009). Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites. Mol. Cell. Proteomics 8, 1382-1390.
12. Brault, M.E., Lauzon, C., and Autexier, C. (2013). Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects. Hum. Mol. Genet. 22, 3498-3507.
13. Cadwell, C., Yoon, H.J., Zebarjadian, Y., and Carbon, J. (1997). The yeast nucleolar protein Cbf5p is involved in rRNA biosynthesis and interacts genetically with the RNA polymerase I transcription factor RRN3. Mol. Cell Biol. 17, 6175-6183.
14. Carrillo, J., Gonzalez, A., Manguan-Garc?a, C., Pintado-Berninches, L., and Perona, R. (2013). p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage. Clin. Transl. Oncol. [Epub ahead of print].
15. Chen, C., Zhao, X., Kierzek, R., and Yu, Y.T. (2010). A flexible RNA backbone within the polypyrimidine tract is required for U2AF65 binding and pre-mRNA splicing in vivo. Mol. Cell. Biol. 30, 4108-4119.
16. Cohen, S.B., Graham, M.E., Lovrecz, G.O., Bache, N., Robinson, P.J., and Reddel, R.R. (2007). Protein composition of catalytically active human telomerase from immortal cells. Science 315, 1850-1853.
17. Darzacq, X., Kittur, N., Roy, S., Shav-Tal, Y., Singer, R.H., and Meier, U.T. (2006). Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells. J. Cell. Biol. 173, 207-218.
18. Davis, D.R. (1995). Stabilization of RNA stacking by pseudouridine. Nucleic Acids Res. 23, 5020-5026.
19. Dephoure, N., Zhou, C., Villen, J., Beausoleil, S.A., Bakalarski, C.E., Elledge, S.J., and Gygi, S.P. (2008). A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA 105, 10762-10767.
20. Dez, C., Noaillac-Depeyre, J., Caizergues-Ferrer, M., and Henry, Y. (2002). Naf1p, an essential nucleoplasmic factor specifically required for accumulation of box H/ACA small nucleolar RNPs. Mol. Cell Biol. 22, 7053-7065.
21. Ding, Z., Wu, C.J., Jaskelioff, M., Ivanova, E., Kost-Alimova, M., Protopopov, A., Chu, G.C., Wang, G., Lu, X., Labrot, E.S., et al. (2012). Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell 148, 896-907.
22. Dokal, I. (2011). Dyskeratosis congenita. Hematology Am. Soc. Hematol. Educ. Program. 2011, 480-486.
23. Dokal, I., Bungey, J., Williamson, P., Oscier, D., Hows, J., and Luzzatto, L. (1992). Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood 80, 3090-3096.
24. Egan, E.D. and Collins, K. (2010). Specificity and stoichiometry of subunit interactions in the human telomerase holoenzyme assembled in vivo. Mol. Cell. Biol. 30, 2775-2786.
25. Ender, C., Krek, A., Friedl?der, M.R., Beitzinger M., Weinmann, L., Chen, W., Pfeffer, S,. Rajewsky, N., and Meister, G. (2008). A human snoRNA with microRNA-like functions. Mol. Cell 32, 519-528.
26. Fatica, A., Dlakic, M., and Tollervey, D. (2002). Naf1p is a box H/ACA snoRNP assembly factor. RNA 8, 1502-1514.
27. Forbes, S.A., Bindal, N., Bamford, S., Cole, C., Kok, C.Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011). COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39 (Database issue), D945-950.
28. Ge, J. and Yu, Y.T. (2013). RNA pseudouridylation: new insights into an old modification. Trends Biochem. Sci. 38, 210-218.
29. Ge, J., Rudnick, D.A., He, J., Crimmins, D.L., Ladenson, J.H., Bessler, M., and Mason, P.J. (2010). Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol. Cell. Biol. 30, 413-422.
30. Giordano, E., Peluso, I., Senger, S., and Furia M. (1999). Minifly, a Drosophila gene required for ribosome biogenesis. J. Cell. Biol. 144, 1123-1133.
31. Grozdanov, P.N., Roy, S., Kittur, N., and Meier, U.T. (2009a). SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs. RNA 15, 1188-1197.
32. Grozdanov, P.N., Fernandez-Fuentes, N., Fiser, A., and Meier, U.T. (2009b). Pathogenic NAP57 mutations decrease ribonucleoprotein assembly in dyskeratosis congenita. Hum. Mol. Genet. 18, 4546-4551.
33. Gu, B.W., Fan, J.M., Bessler, M., and Mason, P.J. (2011). Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment. Aging Cell 10, 338-348.
34. Gu, B.W., Ge, J., Fan, J.M., Bessler, M., and Mason, P.J. (2013). Slow growth and unstable ribosomal RNA lacking pseudouridine in mouse embryonic fibroblast cells expressing catalytically inactive dyskerin. FEBS Lett. 58, 2112-2117.
35. Hamma, T., Reichow, S.L., Varani, G., and Ferr?D'Amar? A.R. (2005). The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs. Nat. Struct. Mol. Biol. 12, 1101-1107.
36. He, J., Navarrete, S., Jasinski, M., Vulliamy, T., Dokal, I., Bessler, M., and Mason, P.J. (2002). Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene 21, 7740-7744.
37. Heiss, N.S., Knight, S.W., Vulliamy, T.J., Klauck, S.M., Wiemann, S., Mason, P.J., Poustka, A., and Dokal, I. (1998). X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19, 32-38.
38. Hoareau-Aveilla, C., Bonoli, M., Caizergues-Ferrer, M., and Henry, Y. (2006). hNaf1 is required for accumulation of human box H/ACA snoRNPs, scaRNPs, and telomerase. RNA 12, 832-840.
39. Hu, J., Hwang, S.S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A.T., Zhang, H., et al. (2012). Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 148, 651-663.
40. Jack, K., Bellodi, C., Landry, D.M., Niederer, R.O., Meskauskas, A., Musalgaonkar, S., Kopmar, N., Krasnykh, O., Dean, A.M., Thompson, S.R., et al. (2011). rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol. Cell 44, 660-666.
41. Jiang, W., Middleton, K., Yoon, H.J., Fouquet, C., and Carbon, J. (1993). An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules. Mol. Cell. Biol. 13, 4884-4893.
42. Jung, C.H., Hansen, M.A., Makunin, I.V., Korbie, D.J., and Mattick, J.S. (2010). Identification of novel non-coding RNAs using profiles of short sequence reads from next generation sequencing data. BMC Genomics 11:77.
43. Karijolich, J. and Yu, Y.T. (2011). Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395-398.
44. Khanna, A. and Stamm, S. (2010). Regulation of alternative splicing by short non-coding nuclear RNAs. RNA Biol. 7, 480-485.
45. Kirwan, M. and Dokal, I. (2008). Dyskeratosis congenita: a genetic disorder of many faces. Clin. Genet. 73, 103-112.
46. Kiss, T., Fayet, E., J?y, B.E., Richard, P. and Weber, M. (2006). Biogenesis and intranuclear trafficking of human box C/D and H/ACA RNPs. Cold Spring Harb. Symp. Quant. Biol. 71, 407-417.
47. Kittur, N., Darzacq, X., Roy, S., Singer, R.H., and Meier, U.T. (2006). Dynamic association and localization of human H/ACA RNP proteins. RNA 12, 2057-2062.
48. Knight, S.W., Heiss, N.S., Vulliamy, T.J., Aalfs, C.M., McMahon, C., Richmond, P., Jones, A., Hennekam, R.C., Poustka, A., Mason, P.J., et al. (1999). Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome). due to mutations in the dyskeratosis congenita gene, DKC1. Br. J. Haematol. 107, 335-339.
49. Lafontaine, D.L. and Tollervey, D. (1998). Birth of the snoRNPs: the evolution of the modification-guide snoRNAs. Trends Biochem. Sci. 23, 383-388.
50. Lestrade, L. and Weber, M.J. (2006). snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res. 34 (Database issue), D158-D162.
51. Leulliot, N., Godin, K.S., Hoareau-Aveilla, C., Quevillon-Cheruel, S., Varani, G., Henry, Y., and Van Tilbeurgh, H. (2007). The box H/ACA RNP assembly factor Naf1p contains a domain homologousto Gar1p mediating its interaction with Cbf5p. J. Mol. Biol. 371, 1338-1353.
52. Li, L. and Ye, K. (2006). Crystal structure of an H/ACA box ribonucleoprotein particle. Nature 443, 302-307.
53. Li, S., Duan, J., Li, D., Yang, B., Dong, M. and Ye, K. (2011). Reconstitution and structural analysis of the yeast box H/ACA RNA-guided pseudouridine synthase. Genes Dev. 25, 2409-2421.
54. Lin, X. and Momany, M. (2003). The Aspergillus nidulans swoC1 mutant shows defects in growth and development. Genetics 165, 543-554.
55. Liu, B., Zhang, J., Huang, C., and Liu, H. (2012). Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis. PLoS One 7, e43147.
56. Luzzatto, L. and Karadimitris, A. (1998). Dyskeratosis and ribosomal rebellion. Nat. Genet. 19, 6-7.
57. Maceluch, J., Kmieciak, M., Szweykowska-Kuli?ska, Z., and Jarmołowski, A. (2001). Cloning and characterization of Arabidopsis thaliana AtNAP57- A homologue of yeast pseudouridine synthase Cbf5p. Acta Biochim. Pol. 48, 699-709.
58. Maden, B.E. (1990). The numerous modified nucleotides in eukaryotic ribosomal RNA. Prog. Nucleic Acid. Res. Mol. Biol. 39, 241-303.
59. Manza, L. L, Codreanu, S.G., Stamer, S.L., Smith, D.L., Wells, K.S., Roberts, R.L., and Liebler, D.C. (2004). Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol. 17, 1706-1715.
60. Mason, P.J. and Bessler, M. (2011). The genetics of dyskeratosis congenita. Cancer Genet. 204, 635-645.
61. McDonald, S.L., Edington, H.D., Kirkwood, J.M., and Becker, D. (2004). Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes. Cancer. Biol. Ther. 3, 110-120.
62. Meier, U.T. and Blobel, G. (1994). NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria. J. Cell Biol. 127, 1505-1514.
63. Mitchell, J.R., Wood, E., and Collins, K. (1999). A telomerase component is defective in the human disease dyskeratosis congenital. Nature 402, 551-555.
64. Mochizuki, Y., He, J., Kulkarni, S., Bessler, M., and Mason, P.J. (2004). Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc. Natl. Acad. Sci. USA 101, 10756-10761.
65. Montanaro, L., Brigotti, M., Clohess, J., Barbieri, S., Ceccarelli, C., Santini, D., Taffurelli, M., Calienni, M., Teruya-Feldstein, J., Trerè, D., et al. (2006). Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J. Pathol. 210, 10-18.
66. Montanaro, L., Calienni, M., Ceccarelli, C., Santini, D., Taffurelli, M., Pileri, S., Treré, D., and Derenzini, M. (2008). Relationship between dyskerin expression and telomerase activity in human breast cancer. Cell Oncol. 30, 483-490.
67. Montanaro, L., Calienni, M., Bertoni, S., Rocchi, L., Sansone, P., Storci, G., Santini, D., Ceccarelli, C., Taffurelli, M., Carnicelli, D., et al. (2010). Novel dyskerin mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res. 70, 4767-4777.
68. Nallar, S.C., Lin, L., Srivastava,V., Gade, P., Hofmann, E.R., Ahmed, H., Reddy, S.P., and Kalvakolanu, D.V. (2011). GRIM-1, a novel growth suppressor, inhibits rRNA maturation by suppressing small nucleolar RNAs. PLoS One 6, e24082.
69. Parry, E.M., Alder, J.K., Lee, S.S., Phillips J.A.3rd, Loyd, J.E., Duggal, P., and Armanios, M. (2011). Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. J. Med. Genet. 48, 327-333.
70. Phillips, B., Billin, A.N., Cadwell, C., Buchholz, R., Erickson, C., Merriam, J.R., Carbon, J., and Poole, S.J. (1998). The Nop60B gene of Drosophila encodes an essential nucleolar protein that functions in yeast. Mol. Gen. Genet. 260, 20-29.
71. Piva, R., Pellegrino, E., Mattioli, M., Agnelli, L., Lombardi, L., Boccalatte, F., Costa, G., Ruggeri, B.A., Cheng, M., Chiarle, R., et al. (2006). Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J. Clin. Invest. 116, 3171-3182.
72. Rashid, R, Liang, B., Baker, D.L., Youssef, O.A., He, Y., Phipps, K., Terns, R.M., Terns, M.P., and Li, H. (2006). Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita. Mol. Cell 21, 249-260.
73. Riccardo, S., Tortoriello, G., Giordano, E., Turano, M., and Furia, M. (2007). The coding/non-coding overlapping architecture of the gene encoding the Drosophila pseudouridine synthase. BMC Mol. Biol. 8, 1-17.
74. Richard, P., Darzacq, X., Bertrand, E., Jády, B.E., Verheggen, C., and Kiss, T (2003). A common sequence motif determines the Cajal body-specific localization of box H/ACA scaRNAs. Embo. J. 22, 4283-4293.
75. Richard, P., Kiss, A.M., Darzacq, X., and Kiss, T. (2006). Cotranscriptional recognition of human intronic box H/ACA snoRNAs occurs in a splicing-independent manner. Mol. Cell Biol. 26, 2540-2549.
76. Rocchi, L., Pacilli, A., Sethi, R., Penzo, M., Schneider, R.J., Treré, D., Bigotti, M., and Montanaro, L. (2013). Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. Nucleic Acids Res. 41, 8308-8318.
77. Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P.H., Cordon-Cardo, C., and Pandolci, P.P. (2003). Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299, 259-262.
78. Sali, A. and Blundell, T.L. (1993). Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815.
79. Salowsky, R., Heiss, N.S., Benner, A., Wittig, R., and Poustka, A. (2002). Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1 binding site is associated with decreased promoter activity. Gene 293, 9-19.
80. Saraiya, A.A. and Wang, C.C. (2008). snoRNA, a novel precursor of microRNA in Giardia lamblia. PLoS Pathog. 4, e1000224.
81. Sauer, G., Korner, R., Hanisch, A., Ries, A., Nigg, E.A. and Sillje, H.H. (2005). Proteome analysis of the human mitotic spindle. Mol. Cell. Proteomics 4, 35-43.
82. Savage, S.A. and Bertuch, A.A. (2010). The genetics and clinical manifestations of telomere biology disorders. Genet. Med. 12, 753-764.
83. Schaner, M.E., Ross, D.T., Ciaravino, G., Soglie, T., Troyanskaya, O., Diehn, M., Wang Y.C., Duran, G.E., Sikic, T.L., Caldeira, S., et al. (2003). Gene expression patterns in ovarian carcinomas. Mol. Biol. Cell 14, 4376-4386.
84. Sieron, P., Hader, C., Hatina, J., Engers, R., Wlazlinski, A., M?ler, M., and Schulz, W.A. (2009). DKC1 overexpression associated with prostate cancer progression. Br. J. Cancer 101, 1410-1416.
85. Taft, R.J., Glazov, E.A., Lassmann, T., Hayashizaki, Y., Carninci, P., and Mattick, J.S. (2009). Small RNAs derived from snoRNAs. RNA 15, 1233-1240.
86. Taulli, R. and Pandolfi, P.P. (2012). 'Snorkeling' for missing players in cancer. J. Clin. Invest. 122, 2765-2768.
87. Tortoriello, G., de Celis, J.F., and Furia, M. (2010). Linking pseudouridine synthases to growth, development and cell competition. FEBS J. 277, 3249-3263.
88. Turano, M., Angrisani, A., De Rosa, M., Izzo, P., and Furia, M. (2008). Real-time PCR quantification of human DKC1 expression in colorectal cancer. Acta Oncol. 47, 1598-1599.
89. Turano, M., Angrisani, A., Di Maio, N., and Furia, M. (2013). Intron retention: a human DKC1 gene common splicing event. Biochem. Cell Biol. 91, 506-512.
90. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. (2010). Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250.
91. von Stedingk, K., Koster, J., Piqueras, M., Noguera, R., Navarro, S., P?lman, S., Versteeg, R., Ora, I., Gisselsson, D., Lindgren, D., et al. (2013). snoRNPs regulate telomerase activity in neuroblastoma and are associated with poor prognosis. Transl. Oncol. 6, 447-457.
92. Vulliamy,T.J., Knight, S.W., Heiss, N.S., Smith, O.P., Poustka, A., Dokal, I., and Mason, P.J. (1999). Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier. Blood 94, 1254-1260.
93. Walbott, H., Machado-Pinilla, R., Liger, D., Blaud, M., R?y, S., Grozdanov, P.N., Godin, K., van Tilbeurgh, H., Varani, G., Meier, U.T., et al. (2011). The H/ACA RNP assembly factor SHQ1 functions as an RNA mimic. Genes Dev. 25, 2398-2408.
94. Watanabe, Y. and Gray, M.W. (2000). Evolutionary appearance of genes encoding proteins associated with box H/ACA snoRNAs: cbf5p in Euglena gracilis, an early diverging eukaryote, and candidate Gar1p and Nop10p homologs in archaebacteria. Nucleic Acids Res. 28, 2342-2352.
95. Westermann, F., Henrich, K.O., Wei, J.S., Lutz, W., Fischer, M., K?ig, R., Wiedemeyer, R., Ehemann, V., Brors, B., Ernestus, K., et al. (2007). High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Clin. Cancer Res. 13, 4695-4703.
96. Westman, B.J., Verheggen, C., Hutten, S., Lam, Y.W., Bertrand, E., and Lamond, A.I. (2010). A proteomic screen for nucleolar SUMO targets shows SUMOylation modulates the function of Nop5/Nop58. Mol. Cell 39, 618-631.
97. Witkowska, A., Gumprecht, J., Glogowska-Ligus, J., Wystrychowski, G., Owczarek, A., Stachowicz, M., Bocianowska, A., Nowakowska-Zajdel, E., and Mazurek, U. (2010). Expression profile of significant immortalization genes in colon cancer. Int. J. Mol. Med. 25, 321-329.
98. Wong, J.M., Kyasa, M.J., Hutchins, L., and Collins, K. (2004). Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum. Genet. 115, 448-455.
99. Wu, G., Yu, A.T., Kantartzis, A., and Yu, Y.T. (2011). Functions and mechanisms of spliceosomal small nuclear RNA pseudouridylation. Wiley Interdiscip. Rev. RNA 2, 571-581.
100. Yaghmai, R., Kimyai-Asadi, A., Rostamiani, K., Heiss, N.S., Poustka, A., Eyaid, W., Bodurtha, J., Nousari, H.C., Hamosh, A., and Metzenberg, A. (2000). Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J. Pediatr. 136, 390-393.
101. Yang, Y., Isaac, C., Wang, C., Dragon, F., Pogacic, V., and Meier, U.T. (2000). Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140. Mol. Biol. Cell. 11, 567-577.
102. Yang, P.K., Rotondo, G., Porras, T., Legrain, P., and Chanfreau, G. (2002). The Shq1pdNaf1p complex is required for box H/ACA small nucleolar ribonucleoprotein particle biogenesis. J. Biol. Chem. 277, 45235-45242.
103. Yang, P.K., Hoareau, C., Froment, C., Monsarrat, B., Henry, Y., and Chanfreau, G. (2005). Cotranscriptional recruitment of the pseudouridylsynthetase Cbf5p and of the RNA binding protein Naf1p during H/ACA snoRNP assembly. Mol. Cell. Biol. 25, 3295-3304.
104. Yoon, A., Peng, G., Brandenburger, Y., Zollo, O., Xu, W., Rego, E., and Ruggero, D. (2006). Impaired control of IRES-mediated translation in X-linked dyskeratosis congenital. Science 312, 902-906.
105. Yu, A.T., Ge, J., and Yu, Y.T. (2011). Pseudouridines in spliceosomal snRNAs. Protein Cell 2, 712-725.
106. Zebarjadian, Y., King, T., Fournier, M.J., Clarke, L., and Carbon, J. (1999). Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol. Cell Biol. 19, 7461-7472.
107. Zeng, X.L., Thumati, N.R., Fleisig, H.B., Hukezalie K.R., Savage, S.A., Giri, N., Alter, B.P., and Wong, J.M. (2012). The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. Hum. Mol. Genet. 21, 721-729.
108. Zhang, Y., Morimoto, K., Danilova, N., Zhang, B., and Lin, S. (2012). Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing. PLoS One 7, e30188.